SIH Partners’s Insmed INSM Stock Holding History

SIH Partners’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,138	Closed	-$350K	–	377
2026 Q1	$350K	Buy	+2,138	New	+$329K	﹤0.01%	235
2025 Q2	–	Sell	-11,415	Closed	-$871K	–	243
2025 Q1	$871K	Buy	+11,415	New	+$873K	0.03%	129

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

SIH Partners's INSM Position: Q2 2026 in Review

SIH Partners sold out of Insmed (INSM) in Q2 2026, closing a stake of 2,138 shares — an estimated $350K sold.

SIH Partners first reported a position in INSM in Q1 2025 and held it in 2 quarters. The position peaked at $871K in Q1 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

SIH Partners reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
SIH Partners sold 2,138 Insmed shares in Q2 2026, an estimated $350K.
SIH Partners first reported a position in Insmed in Q1 2025 and held it in 2 quarters.
SIH Partners's Insmed position peaked at $871K in Q1 2025.
667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on SIH Partners's 13F filing for Q2 2026, filed 14 Aug 2026.